Latest Communications

16 January 2013
MonoSol Rx Enters Into Licensing Agreement With Vestiq Pharmaceuticals for Zuplenz(R) Oral Soluble Film

19 November 2012
APR Applied Pharma Research ("APR") and Labtec GmbH ("Labtec") announce the European approval of two new Oral Dispersible Film (ODF) based respectively on Olanzapine and Donepezil

05 October 2012
Stellar Pharmaceuticals Launches New Migraine Treatment, CAMBIA®, in $150 Million Canadian Prescription Migraine Market


Product Development Plan


All APR products and projects are based on a solid set of scientific data and/or proven technologies but in addition, they are also complemented, supported and maximized by an integrated strategic marketing model.


We define and coordinate the value chain from R&D and technology investments to the final consumer targets in order to deliver competitive products for our healthcare partners as well as effective added value products for patients and consumers.


We focus on strategic product planning: we internally analyze markets, trends and brands in order to identify new product /project opportunities, we identify the best development path for any product/project and we execute and control all the phases in order to deliver to our partners validated products; we finally support our partners and customers during all the launch phases and the commercial lifecycle with an integrated marketing plan.





Search results